New answers tagged

1

Yes. With ample caveats. It shows antiviral activity in the lab, it is often used traditionally in virus-induced diseases. But as an actual prime frontline medicine against viral infection clinical evidence for its use it lacking. Its antiviral activity is well established in vitro. But apart from laboratory settings its efficacy as an actually ...


2

COVID-19 is so new that there are a lot of things that are uncertain. There is some anecdotal evidence that young people can develop significant complication. For example, this article in the Atlantic by a NYC doctor describes a number of young, healthy patients coming to the hospital with significant discomfort and in one case sever inflammation. The New ...


4

This question is probably rather unsuitable for the Skeptics format as it rather a matter of (professional) opinion. Starting with the last quote you gave, which is from a 2006 WebMD article no guaranteed safe way to reuse face masks The way to decrypt that is to read the full quote "There is currently no simple, reliable way to decontaminate these ...


8

I decided to go and look on the website for the research institute in Seattle and they confirm that testing is indeed underway. On March 16, 2020, Kaiser Permanente Washington Health Research Institute (KPWHRI) gave the first-ever injection of an investigational vaccine for the 2019 novel coronavirus, SARS-CoV-2, to 4 volunteers participating in a phase I ...


6

Out of the numerous 2013 mass media stories on this, Reuters managed to correctly report that this was an unpublished study! Rouillon told Reuters that his unpublished work is still in the early stages and he is hesitant about giving one-size-fits-all advice to women, despite the media circus. Also, Rouillon JD doesn't return any hits in pubmed after ...


Top 50 recent answers are included